Equities Analysts Set Expectations for Disc Medicine, Inc.'s

Disc Medicine, Inc. (NASDAQ:IRON – Free Report) – Investment analysts at Leerink Partnrs reduced their Q1 2024 EPS estimates for shares of Disc Medicine in a note issued to investors on Thursday, March 21st. Leerink Partnrs analyst T. Smith now anticipates that the company will earn ($1.10) per share for the quarter, down from their […]

Related Keywords

Wellington , New Zealand General , New Zealand , Kevin Bitterman , Leerink Partnrs , Venture Fund Xlp Atlas , Vanguard Group Inc , Cantor Fitzgerald , Wellington Management Group , Virtu Financial , Nasdaq , Morgan Stanley , Goldman Sachs Group Inc , Financial Services Group Inc , Securities Exchange Commission , Disc Medicine Inc , Disc Medicine Company Profile , Disc Medicine , Free Report , Medicine Stock Down , Venture Fund , Exchange Commission , Director Kevin Bitterman , Services Group , Management Group , Sachs Group , Get Free Report , Disc Medicine Daily , Nasdaq Iron , Iron , Medical , Earnings Estimates ,